GSK-2904545A

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameGSK-2904545A
Drug Alias NameCDIFF Ag - GlaxoSmithKlineClostridium difficile vaccine - GlaxoSmithKline2904545-AGSK-2904545A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A